Journal of Inflammation Research (Dec 2023)
Research Progress on Application of Inonotus obliquus in Diabetic Kidney Disease
Abstract
Shuyue Wang,1 Ruihua Wang,2 Rongshan Li,1 Yafeng Li1 1Department of Nephrology, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, People’s Republic of China; 2The Third Clinical College, Shanxi University of Chinese Medicine, Taiyuan, Shanxi, 030002, People’s Republic of ChinaCorrespondence: Yafeng Li, Department of Nephrology, Shanxi Provincial People’s Hospital, No. 29, Shuangtasi Street, Yingze District, Taiyuan, Shanxi, 030012, People’s Republic of China, Email [email protected]: Diabetic kidney disease (DKD) is one of the prime causes of end-stage renal disease. At present, the treatment of DKD is mainly confined to inhibiting the renin-angiotensin-aldosterone system, but the therapeutic effects is not satisfactory. As a kind of very rare and precious medicinal fungi, Inonotus obliquus has a very high medicinal value. Due to its special hypoglycemic and pharmacological effect, researchers currently have attached great importance to it. In this paper, the biological activities, pharmacological effects and application status in the treatment of DKD-related diseases of Inonotus obliquus and the latest progress of metabolites isolated from it in DKD were summarized, thus providing detailed insights and basic understanding of the potential application prospects in DKD.Keywords: diabetic kidney disease, Inonotus obliquus, triterpenoid, polysaccharide, hypoglycemic effect
